GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 inter alia to consider and approve Unaudited Financial Results for quarter & half year ended 30th September 2024 and to consider the declaration of interim dividend (if any)
हाल में देखा गया
सब क्लियर करें